Page last updated: 2024-10-26

erythrosine and Tuberculosis, Multidrug-Resistant

erythrosine has been researched along with Tuberculosis, Multidrug-Resistant in 2 studies

Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.

Tuberculosis, Multidrug-Resistant: Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Diarra, B1
Decroo, T1
Somboro, A1
Coulibaly, G1
Tolofoudie, M1
Kone, M1
Degoga, B1
Diallo, F1
Togo, ACG1
Sanogo, M1
Sarro, YS1
Cisse, AB1
Kodio, O1
Baya, B1
Kone, A1
Maiga, M1
Dao, S1
Maiga, II1
Murphy, RL1
Siddiqui, S1
Toloba, Y1
Konate, B1
Diakite, M1
Doumbia, S1
Van Deun, A2
Rigouts, L1
Diallo, S1
de Jong, BC2
Maug, AK1
Hossain, A1
Gumusboga, M1

Other Studies

2 other studies available for erythrosine and Tuberculosis, Multidrug-Resistant

ArticleYear
Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in Mali.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2020, 08-01, Volume: 24, Issue:8

    Topics: Drug Resistance, Bacterial; Fluoresceins; Humans; Mali; Molecular Diagnostic Techniques; Mycobacteri

2020
Fluorescein diacetate vital staining allows earlier diagnosis of rifampicin-resistant tuberculosis.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012, Volume: 16, Issue:9

    Topics: Antibiotics, Antitubercular; Bangladesh; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Fluo

2012